🔗 Share this article

A shadow market for unapproved weight-loss medications is propelled by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Experimental Treatment Gaining Traction Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to message these profiles directly for source information, while also obtaining discount codes.

Thriving Trade on Social Networks

Additionally, a robust trade exists on messaging services, where communities with thousands of members share “before and after” photos, administration instructions and claims of next-day UK delivery. Vendors market the drug there before redirecting buyers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Professionals Express Concerns

However, physicians and pharmacists have cautions that the distribution of what remains an unapproved medication in the UK is a cause for concern and could result in individuals administering products of unknown origin.

Some professionals stated the popularity for the experimental drug could be connected to the increasing price of approved slimming products such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach pharmaceutical, marketing, and customer regulations, risking fines, legal action or prison.

Platform Reaction and Material Elimination

Based on the social media company, the platform has taken down problematic content and banned associated hashtags and search suggestions. The organization said it was committed to maintaining the platform safe and investing in enhancing enforcement strategies.

Online Trading Activities

Research also found groups with up to nine thousand participants selling the experimental drug using the platform's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of members, populated with photos of slimming results, positive reviews and step-by-step instructions for mixing or injecting at residence.

After moments of entering one group, a seller posted contact information, where most purchases take place. The seller provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about weight, health issues or past usage.

Product Information and Costs

Inside these communities, messages show black plastic parcels with postal service labels, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with sterile water, or ready-to-use pens typically priced at 160 pounds for 20mg. When asked how long a pen should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for the messaging service stated it actively monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering substances they can’t verify. Even if the research behind this drug is valid, these digital products may not contain what they advertise,” stated Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.

Her staff has previously seen patients harmed by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this point no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company investigational substance not yet authorized … may expose users to potentially significant medical dangers”.